# TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung Cancer

> **NCT00940069** · PHASE2 · COMPLETED · sponsor: **Hunan Province Tumor Hospital** · enrollment: 60 (actual)

## Conditions studied

- Non-small-cell Lung Cancer
- Adenocarcinoma

## Interventions

- **DRUG:** pemetrexed

## Key facts

- **NCT ID:** NCT00940069
- **Lead sponsor:** Hunan Province Tumor Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2013-06
- **Final completion:** 2015-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00940069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00940069, "TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung Cancer". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00940069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*